STOCK TITAN

Abacus Global Management SEC Filings

ABX NYSE

Welcome to our dedicated page for Abacus Global Management SEC filings (Ticker: ABX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Abacus Global Management, Inc. (NYSE: ABX) SEC filings page on Stock Titan is intended to provide investors with access to the company’s regulatory disclosures once they are available through the U.S. Securities and Exchange Commission. As an alternative asset management firm focused on longevity-based assets, insurance-related strategies, and asset-based finance, Abacus’s filings are expected to contain detailed information about its business verticals, fee-related earnings, and risk factors.

Key documents for ABX typically include annual reports on Form 10-K and quarterly reports on Form 10-Q, which explain the performance and structure of its Life Solutions division, Abacus Asset Group, ABL Tech, and Abacus Wealth Advisors. These reports generally describe how the company originates and manages life insurance and other insurance-centric assets, how it structures longevity funds and asset-based finance strategies, and how it generates revenue from origination gains, management fees, servicing fees, and advisory income.

Other important filings may include current reports on Form 8-K that discuss material events such as new securitized product offerings backed by life insurance assets, strategic acquisitions like digital life insurance origination platforms, and updates to dividend policies or capital allocation frameworks. Proxy statements on Schedule 14A can provide insight into governance matters and board oversight of the company’s alternative asset management activities.

Stock Titan enhances access to Abacus filings by offering AI-powered summaries that explain complex sections of lengthy documents, highlight key themes in 10-K and 10-Q reports, and help users interpret disclosures related to insurance analytics, asset-based finance strategies, and fee-related earnings. Real-time updates from EDGAR, combined with tools to review insider transaction reports on Form 4 when available, allow investors to monitor regulatory information about ABX in a centralized, easy-to-navigate format.

Rhea-AI Summary

Abacus Global Management, Inc. reported that Chief Financial Officer William Hugh McCauley Jr. acquired 357,770 shares of common stock through a grant of restricted stock units. These units were tied to performance-based goals set on May 8, 2025, which have now been met. The RSUs will vest in three equal installments on each of the first three anniversaries of the grant date, and following this award he holds 1,152,770 common shares directly. This is a compensation-related equity grant rather than an open-market purchase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Abacus Global Management, Inc. reported that Chief Financial Officer William Hugh McCauley Jr. acquired 357,770 shares of common stock through a grant of restricted stock units. These units were tied to performance-based goals set on May 8, 2025, which have now been met. The RSUs will vest in three equal installments on each of the first three anniversaries of the grant date, and following this award he holds 1,152,770 common shares directly. This is a compensation-related equity grant rather than an open-market purchase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Abacus Global Management, Inc. reported that Co-Founder and President Sean McNealy acquired 211,742 shares of common stock through a compensation-related grant. The shares reflect restricted stock units that were originally granted on May 8, 2025 once performance conditions were met. The RSUs will vest in three equal annual installments from the grant date. Following this award, McNealy directly holds 12,676,712 shares of common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Abacus Global Management, Inc. reported that Co-Founder and President Sean McNealy acquired 211,742 shares of common stock through a compensation-related grant. The shares reflect restricted stock units that were originally granted on May 8, 2025 once performance conditions were met. The RSUs will vest in three equal annual installments from the grant date. Following this award, McNealy directly holds 12,676,712 shares of common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Abacus Global Management, Inc. Co-Founder and President Kirby Kevin Scott reported an acquisition of 211,742 shares of Common Stock as a compensation grant. These shares represent Restricted Stock Units tied to performance goals that have now been met and will vest in three equal annual installments starting from the grant date. Following this grant, Scott directly holds 12,676,412 shares of Common Stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Abacus Global Management, Inc. Co-Founder and President Kirby Kevin Scott reported an acquisition of 211,742 shares of Common Stock as a compensation grant. These shares represent Restricted Stock Units tied to performance goals that have now been met and will vest in three equal annual installments starting from the grant date. Following this grant, Scott directly holds 12,676,412 shares of Common Stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Abacus Global Management Co-Founder and President Matthew Ganovsky received 211,742 shares of common stock through a restricted stock unit award. The RSUs were originally granted on May 8, 2025 with performance-based vesting, and the performance conditions have now been satisfied.

The RSUs will vest in three equal annual installments, with one-third of the satisfied amount vesting on each of the first three anniversaries of the May 8, 2025 grant date. Following this compensation-related acquisition, Ganovsky directly holds 8,821,366 shares of Abacus Global Management common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Abacus Global Management Co-Founder and President Matthew Ganovsky received 211,742 shares of common stock through a restricted stock unit award. The RSUs were originally granted on May 8, 2025 with performance-based vesting, and the performance conditions have now been satisfied.

The RSUs will vest in three equal annual installments, with one-third of the satisfied amount vesting on each of the first three anniversaries of the May 8, 2025 grant date. Following this compensation-related acquisition, Ganovsky directly holds 8,821,366 shares of Abacus Global Management common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Abacus Global Management, Inc. director Corbett Thomas Wingett JR received a grant of 17,327 shares of Common Stock at $10.10 per share. After this award on March 12, 2026, his directly held Common Stock position increased to 45,059 shares, reflecting a routine compensation-related acquisition rather than an open-market purchase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Abacus Global Management, Inc. director Corbett Thomas Wingett JR received a grant of 17,327 shares of Common Stock at $10.10 per share. After this award on March 12, 2026, his directly held Common Stock position increased to 45,059 shares, reflecting a routine compensation-related acquisition rather than an open-market purchase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

van Katwijk Cornelis Michiel reported acquisition or exercise transactions in this Form 4 filing.

Abacus Global Management, Inc. director Cornelis Michiel van Katwijk received a compensation-related grant of 17,327 shares of Common Stock on 2026-03-12 at $10.10 per share. After this award, he directly holds 35,059 shares, reflecting an increase in his equity stake without an open-market purchase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

van Katwijk Cornelis Michiel reported acquisition or exercise transactions in this Form 4 filing.

Abacus Global Management, Inc. director Cornelis Michiel van Katwijk received a compensation-related grant of 17,327 shares of Common Stock on 2026-03-12 at $10.10 per share. After this award, he directly holds 35,059 shares, reflecting an increase in his equity stake without an open-market purchase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Abacus Global Management, Inc. director Gusky Adam Samuel received a grant of 17,327 shares of common stock at a value of $10.10 per share. This award is classified as a grant or other acquisition, not an open-market purchase, bringing his directly held stake to 86,644 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Abacus Global Management, Inc. director Gusky Adam Samuel received a grant of 17,327 shares of common stock at a value of $10.10 per share. This award is classified as a grant or other acquisition, not an open-market purchase, bringing his directly held stake to 86,644 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Abacus Global Management, Inc. director Mary Beth Schulte reported a compensation-related stock award rather than an open-market trade. On March 12, 2026, she acquired 20,792 shares of Common Stock at $10.10 per share. Following this grant, her direct holdings increased to 55,070 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Abacus Global Management, Inc. director Mary Beth Schulte reported a compensation-related stock award rather than an open-market trade. On March 12, 2026, she acquired 20,792 shares of Common Stock at $10.10 per share. Following this grant, her direct holdings increased to 55,070 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Radka Karla reported acquisition or exercise transactions in this Form 4 filing.

Abacus Global Management director Radka Karla reported receiving a grant of 17,327 shares of common stock on March 12, 2026 at a reported value of $10.10 per share. This compensation-related award increased her direct holdings to 35,059 shares, and involved no open-market buying or selling.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Radka Karla reported acquisition or exercise transactions in this Form 4 filing.

Abacus Global Management director Radka Karla reported receiving a grant of 17,327 shares of common stock on March 12, 2026 at a reported value of $10.10 per share. This compensation-related award increased her direct holdings to 35,059 shares, and involved no open-market buying or selling.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Abacus Global Management reported a very strong 2025, with fourth-quarter revenue rising 116% to $71.9 million and full-year revenue up 110% to $235.2 million, driven mainly by Life Solutions and Asset Management growth.

The company swung from a prior-year GAAP net loss to 2025 GAAP net income of $36.5 million, while Adjusted net income climbed 84% to $85.7 million. Full-year Adjusted EBITDA rose 115% to $132.6 million with a 56% margin, and both ROE and ROIC reached 20%, highlighting improved profitability.

Abacus initiated a 2026 Adjusted net income outlook of $96–$104 million, implying growth of up to 22%, and ended 2025 with $38.1 million in cash and $405.8 million of debt. The company also agreed to acquire an approximately $53 million minority equity stake in Manning & Napier, a wealth and asset manager with about $18 billion in assets under management, alongside a strategic alliance covering product distribution, referrals, and joint product development.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Abacus Global Management reported a very strong 2025, with fourth-quarter revenue rising 116% to $71.9 million and full-year revenue up 110% to $235.2 million, driven mainly by Life Solutions and Asset Management growth.

The company swung from a prior-year GAAP net loss to 2025 GAAP net income of $36.5 million, while Adjusted net income climbed 84% to $85.7 million. Full-year Adjusted EBITDA rose 115% to $132.6 million with a 56% margin, and both ROE and ROIC reached 20%, highlighting improved profitability.

Abacus initiated a 2026 Adjusted net income outlook of $96–$104 million, implying growth of up to 22%, and ended 2025 with $38.1 million in cash and $405.8 million of debt. The company also agreed to acquire an approximately $53 million minority equity stake in Manning & Napier, a wealth and asset manager with about $18 billion in assets under management, alongside a strategic alliance covering product distribution, referrals, and joint product development.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

How many Abacus Global Management (ABX) SEC filings are available on StockTitan?

StockTitan tracks 74 SEC filings for Abacus Global Management (ABX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Abacus Global Management (ABX)?

The most recent SEC filing for Abacus Global Management (ABX) was filed on March 16, 2026.